Science
Iridium catalyst activates chemotherapy drug directly at targeted cancer cells
Source: Phys.org · Published
Conventional chemotherapy treatments often attack not only cancer cells but also healthy tissue, leading to severe side effects such as hair loss or nausea. The team led by Dr. Thomas Ward from the Department of Chemistry and the Swiss Nanoscience Institute (SNI) at the University of Basel is therefore pursuing an approach that uses artificial metal compounds as catalysts that specifically bind…
Related stories
- As it gets harder to figure out what to eat, some Americans are turning to religion for answers
Phys.org · 3 Nov 2026, 20:20
- Reading single vesicles reveals clues to the origin of chronic inflammation
Phys.org · 3 Nov 2026, 20:20
- Researchers target PFAS with lower-temperature destruction method
Phys.org · 3 Nov 2026, 20:00
- Global accounting reveals economic toll of ecosystem losses from rising seas
Phys.org · 3 Nov 2026, 20:00
- Silent lakes ahead? Long-term study finds common loon productivity is dropping across North America
Phys.org · 3 Nov 2026, 19:40
- Microbiome research reveals how bacterial lipids influence liver and muscle health in mice
Phys.org · 3 Nov 2026, 19:40
We are a news aggregator: we show the headline and a short excerpt with a link to the original source. We never republish full articles.